Betulinic acid induces apoptosis in human neuroblastoma cell lines

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 2007-2010

  Schmidt, M L ^a   Kuzmanoff, K L ^a   Ling Indeck, L ^a   Pezzuto, J M ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Apoptosis; Betulinic acid; Neuroblastoma

Indexed keywords

BETULIC ACID;

ADVANCED CANCER; APOPTOSIS; CANCER CELL; CELL DEATH; CELL PROLIFERATION; CONFERENCE PAPER; FETUS DEVELOPMENT; GENE AMPLIFICATION; HUMAN; HUMAN CELL; NEURAL CREST; NEUROBLASTOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; DNA FRAGMENTATION; DNA, NEOPLASM; HUMANS; NEUROBLASTOMA; TRITERPENES; TUMOR CELLS, CULTURED;

EID: 0031426988     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00294-3     Document Type: Conference Paper

References (20)

1. Arends M. J., Wyllie A. H. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol. 32:1991;223-254.
2. De Bernardi B, Rogers D, Carli M, et al. Localized neuroblastoma. Surgical and pathologic staging. Cancer 1987, 60, 1066-1072.
3. Brodeur G, Azar C, Brother M, et al. Neuroblastoma. Effect of genetic factors on prognosis and treatment. Cancer 1992, 70, 1685-1694.
4. Seeger R, Brodeur G, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313, 1111-1116.
5. Zimmerman K, Yancopoulos G, Collum R, et al. Differential expression of myc family genes during murine development. Nature 1986, 319, 780-783.
6. Pritchard J., Hickman J. Why does stage 4s neuroblastoma regress spontaneously? Lancet. 344:1991;869-870.
7. Reed J. J. Bcl-2 and the regulation of programmed cell death. Cell Biol. 124:1994;1-6.
8. Castle V, Heidelberger K, Bromberg J, et al. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Pathology 1993, 143, 1543-1550.
9. Dole M, Nunez G, Merchant A, et al. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 1994, 54, 3253-3259.
10. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 55:1995;2576-2782.
11. Bordow S., Haber M., Madafiglio J., et al. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res. 54:1994;5036-5040.
12. Oltvai Z., Milliman C., Korsmeyer S. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
13. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bc1-2 and bax gene expression in vitro and in vivo. Oncogene 1994, 9, 1799-1805.
14. Pisha E, Chai H, Lee I-S, et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nature Med 1995, 1, 1046-1050.
15. Cohn SL, Salwen H, Quasney MW, et al. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification. Oncogene 1990, 5, 1821-1827.
16. Schmidt M., Salwen H., Monahar C., Ikegaki N., Cohn S. The biological effects of antisense N-myc expression in human neuroblastoma. Cell Growth Differ. 5:1994;171-178.
17. Kubota T, Takahara T, Nagata M, et al. Colorimetric chemosensitivity testing using sulforhodamine B. J Surg Oncol 1993, 52, 83-88.
18. Jacobson MD, Baine JF, King MP, et al. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993, 361, 365-369.
19. Compton M. A biochemical hallmark of apoptosis: Internucleosomal degradation of the genome. Cancer Metast Rev. 11:1992;105-119.
20. Ritke MK, Rusnak JM, Lazo JS, et al. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells. Mol Pharmacol 1994, 46, 605-611.